Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation
Globe Newswire•18/08/2026•08:00 ET
0
Whiz Insights
Get started
Create a free account to read the full story.